Multiple Sclerosis Journal · 2018 · 30 citations · 19 references
Life SciencesImmunologyPathobiologyAutoimmunityImmunopathologyNeuroimmunologyAutoimmune DiseasesCerebrospinal Fluid ImmunologyHelper T Cell SubsetsHumoral ImmunityMultiple SclerosisRegulatory T CellsCerebrospinal Fluid ImmunophenotypingFollicular Helper T CellsIntrathecal Immunoglobulin SynthesisMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyPeripheral Regulatory T CellsT Follicular Helper CellsT Helper Cell Balance
Background: Alteration of T-follicular helper (TFH) and regulatory (TFR) subpopulations may contribute to the development of auto-reactive B-cell. Objective: To investigate whether changes in TFH and TFR subsets are associated with abnormal IgG synthesis in blood and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. Methods: Paired blood and CSF samples were obtained from 31 untreated relapsing-remitting multiple sclerosis (RRMS) patients at diagnosis. Peripheral blood TFH (CD3+CD4+CXCR5+CD25–CD127+), TFR (CD3+CD4+CXCR5+CD25+CD127 dim ), conventional T-Helper (TH, CD3+CD4+CXCR5–CD25–CD127+), and regulatory T-cells (T-Reg, CD3+CD4+CXCR5–CD25+CD127 dim ) were analyzed in all RRMS patients and in 13 healthy controls (HCs). Qualitative and quantitative intrathecal IgG synthesis was evaluated in RRMS patients, who were then further subclassified according to the presence of IgG oligoclonal bands in blood and/or CSF. Results: Compared to HC, RRMS had lower TFR percentage ( p < 0.01) and higher TFH/TFR ratio ( p < 0.001). In RRMS, TFH/TFR ratio correlated with both qualitative ( r = 0.56, p < 0.005) and quantitative intrathecal IgG synthesis (IgG Index: r = 0.78; IgGLoc: r = 0.79; IgGIF: r = 0.76, all p < 0.001). Patients with the highest TFH/TFR ratios had higher percentages of circulating B-cells (36.1 ± 35.2%, p < 0.05). Conclusion: In RRMS, increased TFH/TFR ratio associates with abnormal IgG production in blood and CSF, suggesting that antibody-producing cells, derived from deregulated peripheral germinal center reaction, colonize the CNS.
19
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 2K citations · Full text
Life Sciences, Immunology, Neurology +17
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text
Life Sciences, Immunology, Neurology +17
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti, Bogdan Popescu, Reem F. Bunyan et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell, Cheryl Reeves, Richard Nicholas et al. · Brain · 2011 · 857 citations
Life Sciences, Neurology, Pathology +17